Thompson Davis & Co’s Marker Therapeutics MRKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
$15K Hold
163
0.03% 387
2018
Q2
$15K Buy
+163
New +$15K 0.04% 367